Pharmaceutical companies can confidentially analyze de-identified EMR histories for observational studies, synthetic external control arms, finding patients who fit trial criteria, or other real world data use cases
Clinically Innovative Partnerships For Pharmaceutical Sponsors
How we work before we are contracted for a specific protocol
Our in-house physicians build data dictionaries specializing our algorithms to disease types
We work synergetically with trial site IRB’s to keep all data queries within their healthcare systems firewalls in a regulatory compliant manner. Only trial site research teams are able to identify their own patients.
Our NLP extracts clinical datapoints relevant for clinical research protocols
How pharma sponsors can contract with us
Mutual CDA’s signed
We scope your protocol for patient population size, complexity of criteria and data point availability
We provide you with a proposed plan of action to match de-identified patients to trials, along with timeline and cost
Once we are working with pharma sponsors on a live contract
We work with healthcare systems within our partner network and/or pharma’s trial site network for approvals, compliance, and observational clinical study data
Our studies take the purpose of one of the following use cases for specific disease indications: